XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segments (Tables)
9 Months Ended
Sep. 30, 2023
Business Segments [Abstract]  
Segment Reporting Information by Segment
The following tables reflect results of operations from the Company’s business segments for the periods indicated below:

   
Dermatology
Recurring
Procedures
   
Dermatology
Procedures
Equipment
   
TOTAL
 
Three Months Ended September 30, 2023                  
Revenues, net
 
$
5,280
   
$
3,572
   
$
8,852
 
Cost of revenues
   
2,229
     
1,669
     
3,898
 
Gross profit
   
3,051
     
1,903
     
4,954
 
Gross profit %
   
57.8
%
   
53.3
%
   
56.0
%
                         
Allocated expenses:
                       
Engineering and product development
   
180
     
68
     
248
 
Selling and marketing
   
2,530
     
508
     
3,038
 
Unallocated expenses
   
     
     
2,283
 

   
2,710
     
576
     
5,569
 
Income (loss) from operations
   
341
   
1,327
     
(615
)
Interest expense
   
     
     
(528
)
Interest income
                90  
Net income (loss)
 
$
341
 
$
1,327
   
$
(1,053
)
         
   
Dermatology
Recurring
Procedures
   
Dermatology
Procedures
Equipment
   
TOTAL
 
Nine Months Ended September 30, 2023                  
Revenues, net
 
$
15,945
   
$
8,724
   
$
24,669
 
Cost of revenues
   
6,454
     
4,555
     
11,009
 
Gross profit
   
9,491
     
4,169
     
13,660
 
Gross profit %
    59.5 %     47.8 %     55.4 %
                         
Allocated expenses:
                       
Engineering and product development
   
714
     
223
     
937
 
Selling and marketing
   
8,733
     
1,463
     
10,196
 
Unallocated expenses
   
     
     
7,690
 

   
9,447
      1,686      
18,823
 
Income (loss) from operations
    44     2,483       (5,163 )
Loss on debt extinguishment                 (909 )
Interest expense
   
     
     
(1,112
)
Interest income
                148  
Net income (loss)
 
$
44
 
$
2,483
   
$
(7,036
)

   
Dermatology
Recurring
Procedures
   
Dermatology
Procedures
Equipment
   
TOTAL
 
Three Months Ended September 30, 2022                        
Revenues, net
 
$
5,847
   
$
3,566
   
$
9,413
 
Cost of revenues
   
2,057
     
1,557
     
3,614
 
Gross profit
   
3,790
     
2,009
     
5,799
 
Gross profit %
   
64.8
%
   
56.3
%
   
61.6
%
                         
Allocated expenses:
                       
Engineering and product development
   
139
     
77
     
216
 
Selling and marketing
   
3,296
     
458
     
3,754
 
Unallocated expenses
   
     
     
2,615
 
     
3,435
     
535
     
6,585
 
Income (loss) from operations
   
355
   
1,474
     
(786
)
Interest expense
   
     
     
(244
)
Interest income                 35  
Net income (loss)
 
$
355
 
$
1,474
   
$
(995
)

   
Dermatology
Recurring
Procedures
   
Dermatology
Procedures
Equipment
   
TOTAL
 
Nine Months Ended September 30, 2022                        
Revenues, net
 
$
16,496
   
$
9,063
   
$
25,559
 
Cost of revenues
   
6,387
     
4,252
     
10,639
 
Gross profit
   
10,109
     
4,811
     
14,920
 
Gross profit %
   
61.3
%
   
53.1
%
   
58.4
%
                         
Allocated expenses:
                       
Engineering and product development
   
398
     
190
     
588
 
Selling and marketing
   
10,225
     
1,291
     
11,516
 
Unallocated expenses
   
     
     
7,599
 

   
10,623
     
1,481
     
19,703
 
(Loss) income from operations
   
(514
)
   
3,330
     
(4,783
)
Interest expense
   
     
     
(651
)
Interest income
                45  
Net (loss) income
 
$
(514
)
 
$
3,330
   
$
(5,389
)
Depreciation and Amortization by Reportable Segment

For the three and nine months ended September 30, 2023 and 2022, depreciation and amortization by reportable segment were as follows:


   
Three Months Ended September 30,
 
   
2023
   
2022
 
Dermatology recurring procedures
 
$
1,220
   
$
1,175
 
Dermatology procedures equipment
   
225
     
132
 
Unallocated expenses
   
4
     
4
 
Consolidated total
 
$
1,449
   
$
1,311
 

   
Nine Months Ended September 30,
 
   
2023
   
2022
 
Dermatology recurring procedures
 
$
3,671
   
$
3,386
 
Dermatology procedures equipment
   
592
     
574
 
Unallocated expenses
   
11
     
11
 
Consolidated total
 
$
4,274
   
$
3,971
 
Disaggregation of Revenue by Geographical Region
The following tables present the Company’s revenue disaggregated by geographical region for the three and nine months ended September 30, 2023 and 2022, respectively. Domestic refers to revenue from customers based in the United States, and foreign revenue is derived from sales to the Company’s distributors, primarily in Asia.

   
Dermatology Recurring Procedures
   
Dermatology Procedures Equipment
   
TOTAL
 
Three Months Ended September 30, 2023                        
Domestic
 
$
4,960
   
$
879
   
$
5,839
 
Foreign
   
320
     
2,693
     
3,013
 
Total
 
$
5,280
   
$
3,572
   
$
8,852
 
                         
Nine Months Ended September 30, 2023                        
Domestic
 
$
14,948
   
$
2,301
   
$
17,249
 
Foreign
   
997
     
6,423
     
7,420
 
Total
 
$
15,945
   
$
8,724
   
$
24,669
 

   
Dermatology Recurring Procedures
   
Dermatology Procedures Equipment
   
TOTAL
 
Three Months Ended September 30, 2022                        
Domestic
 
$
5,527
   
$
572
   
$
6,099
 
Foreign
   
320
     
2,994
     
3,314
 
Total
 
$
5,847
   
$
3,566
   
$
9,413
 
                         
Nine Months Ended September 30, 2022                        
Domestic
 
$
15,393
   
$
1,814
   
$
17,207
 
Foreign
   
1,103
     
7,249
     
8,352
 
Total
 
$
16,496
   
$
9,063
   
$
25,559